These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26617173)

  • 1. [Post-exposure prophylaxis against measles].
    Følsgaard NV; Nygaard U; Christiansen CB; Harder KM; Andersen PH; Poulsen A
    Ugeskr Laeger; 2015 Nov; 177(48):V06150467. PubMed ID: 26617173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated protective effectiveness of intramuscular immune serum globulin post-exposure prophylaxis during a measles outbreak in British Columbia, Canada, 2014.
    Bigham M; Murti M; Fung C; Hemming F; Loadman S; Stam R; Van Buynder P; Lem M
    Vaccine; 2017 May; 35(20):2723-2727. PubMed ID: 28392140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended.
    Young MK; Ng SK; Nimmo GR; Cripps AW
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):663-669. PubMed ID: 29865869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of prophylaxis for measles contacts in NSW.
    Sheppeard V; Forssman B; Ferson MJ; Moreira C; Campbell-Lloyd S; Dwyer DE; McAnulty JM
    N S W Public Health Bull; 2009; 20(5-6):81-5. PubMed ID: 19552854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles.
    Young MK
    Hum Vaccin Immunother; 2019; 15(9):2060-2065. PubMed ID: 31116633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of measles vaccination for control of exposed children.
    Barrabeig I; Rovira A; Rius C; Muñoz P; Soldevila N; Batalla J; Domínguez A
    Pediatr Infect Dis J; 2011 Jan; 30(1):78-80. PubMed ID: 20844460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of measles spread on a paediatric ward.
    Tapisiz A; Polat M; Kara SS; Tezer H; Simsek H; Aktas F
    Epidemiol Infect; 2015 Mar; 143(4):720-4. PubMed ID: 24877882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current efficacy of postexposure prophylaxis against measles with immunoglobulin.
    Endo A; Izumi H; Miyashita M; Taniguchi K; Okubo O; Harada K
    J Pediatr; 2001 Jun; 138(6):926-8. PubMed ID: 11391343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review.
    Manikkavasagan G; Ramsay M
    J Obstet Gynaecol; 2009 Oct; 29(7):572-5. PubMed ID: 19757257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of measles containment in an ambulatory pediatric clinic.
    Wendorf KA; Kay M; Ortega-Sanchez IR; Munn M; Duchin J
    Pediatr Infect Dis J; 2015 Jun; 34(6):589-93. PubMed ID: 25973936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccination in HIV-infected children.
    Rose VL; Preboth M
    Am Fam Physician; 1999 Nov; 60(7):2179. PubMed ID: 10569516
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preventive value of measles-specific gamma globulins].
    Bardare M; Peregrini C
    Minerva Pediatr; 1972 Jan; 24(2):67-71. PubMed ID: 5011573
    [No Abstract]   [Full Text] [Related]  

  • 14. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines.
    Quiambao BP; Dy-Tioco HZ; Dizon RM; Crisostomo ME; Teuwen DE
    Vaccine; 2009 Nov; 27(51):7162-6. PubMed ID: 19925947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Manikkavasagan G, Ramsay M. 2009. The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. Journal of Obstetrics and Gynaecology 29(7):574-577.
    Manikkavasagan G; Brown K; Ramsay M
    J Obstet Gynaecol; 2010 Feb; 30(2):218. PubMed ID: 20144000
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measles morbidity against a background of mass vaccinal prophylaxis in Kara-Su District, Osh Province].
    Nurakhunov NN
    Zdravookhr Kirg; 1978; (1):27-31. PubMed ID: 24934
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in the control of measles in Ghana, 1980-2000.
    Bosu WK; Essel-Ahun M; Adjei S; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S44-50. PubMed ID: 12721890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling vaccination programmes against measles in Taiwan.
    Chen SC; Chang CF; Jou LJ; Liao CM
    Epidemiol Infect; 2007 Jul; 135(5):775-86. PubMed ID: 17064459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles at Disneyland, a problem for all ages.
    Halsey NA; Salmon DA
    Ann Intern Med; 2015 May; 162(9):655-6. PubMed ID: 25751746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.